HomeOVID • NASDAQ
Ovid Therapeutics Inc
add
$1.29
6.61%
After Hours:(0.78%)+0.0100
$1.30
Closed: Sep 22, 7:00:36 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 6.27M | 3,611.24% |
Operating expense | 11.35M | -45.16% |
Net income | -4.68M | -154.97% |
Net profit margin | -74.68 | -101.48% |
Earnings per share | -0.06 | -150.00% |
EBITDA | -4.97M | 75.58% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 38.35M | -50.18% |
Total assets | 77.43M | -34.43% |
Total liabilities | 21.64M | -25.87% |
Total equity | 55.79M | — |
Shares outstanding | 71.11M | — |
Price to book | 1.55 | — |
Return on assets | -15.94% | — |
Return on capital | -17.66% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -4.68M | -154.97% |
Cash from operations | -4.77M | 66.51% |
Cash from investing | 12.05M | -6.00% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 7.28M | 775.23% |
Free cash flow | -3.08M | 55.39% |
Previous close
$1.21
Day range
$1.19 - $1.33
Year range
$0.24 - $1.47
Market cap
91.73M USD
Avg Volume
1.77M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Website
Employees
23
